MedPath

Pharmaceutical Companies

Soleno Therapeutics, Inc. logo

Soleno Therapeutics, Inc.

🇺🇸United States
Ownership
Public, Subsidiary
Established
1999-08-25
Employees
42
Market Cap
$1.9B
Website
http://www.soleno.life
Ownership
Public, Subsidiary
Established
1984-01-01
Employees
5K
Market Cap
$1.8B
Website
http://www.sumitomo-pharma.co.jp
Ownership
-
Established
-
Employees
-
Market Cap
$1.8B
Website
-
Neumora Therapeutics logo

Neumora Therapeutics

🇺🇸United States
Ownership
Public
Established
2019-01-01
Employees
124
Market Cap
$1.8B
Website
http://www.neumoratx.com
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for...
Ownership
-
Established
-
Employees
-
Market Cap
$1.8B
Website
https://fusionpharma.com/
Akero Therapeutics logo

Akero Therapeutics

🇺🇸United States
Ownership
Public
Established
2017-01-01
Employees
56
Market Cap
$1.8B
Website
http://www.akerotx.com
Akero Therapeutics, Inc. is a clinical-stage company, which engages in the development of treatments for patients with serious metabolic diseases. The firm's lead product candidate, efruxifermin (EFX), is an analog of fibroblast growth...
ProKidney, LLC logo

ProKidney, LLC

🇺🇸United States
Ownership
-
Established
-
Employees
-
Market Cap
$1.8B
Website
-
Immunocore Ltd logo

Immunocore Ltd

🇺🇸United States
Ownership
-
Established
-
Employees
-
Market Cap
$1.8B
Website
-

Novavax

🇺🇸United States
Ownership
-
Established
-
Employees
1.5K
Market Cap
$1.7B
Website
-
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Syndax Pharmaceuticals

🇺🇸United States
Ownership
-
Established
-
Employees
184
Market Cap
$1.7B
Website
-
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber,...
© Copyright 2025. All Rights Reserved by MedPath